Efficacy and Safety of OPANA ER (Oxymorphone Extended Release) for Relief of Moderate to Severe Chronic Low Back Pain in Opioid-Experienced Patients: A 12-Week, Randomized, Double-blind, Placebo-controlled Study-Reference-Cited by-同舟云学术

Efficacy and Safety of OPANA ER (Oxymorphone Extended Release) for Relief of Moderate to Severe Chronic Low Back Pain in Opioid-Experienced Patients: A 12-Week, Randomized, Double-blind, Placebo-controlled Study

Published:2007-02 Issue:2 Volume:8 Page:175-184
ISSN:1526-5900
Container-title:The Journal of Pain
language:en
Short-container-title:The Journal of Pain

Author:

Hale Martin E.,Ahdieh Harry,Ma Tina,Rauck Richard

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Clinical Neurology,Neurology

Reference32 articles.

1. Oxymorphone extended release does not affect CYP2C9 or CYP3A4 metabolic pathways;Adams;J Clin Pharmacol,2005

2. Pharmacokinetics and dose-proportionality of oxymorphone extended release and its metabolites: results of a randomized crossover study;Adams;Pharmacotherapy,2004

3. Single- and multiple-dose pharmacokinetic and dose-proportionality study of oxymorphone immediate-release tablets;Adams;Drugs R D,2005

4. Efficacy of oxymorphone extended release in postsurgical pain: A randomized clinical trial in knee arthroplasty;Ahdieh;J Clin Pharmacol,2004

5. Transdermal fentanyl versus sustained release oral morphine in strong-opioid naive patients with chronic low back pain;Allan;Spine,2005

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of success of pharmacological management in patients with chronic lower back pain: systematic review;Journal of Orthopaedic Surgery and Research;2024-04-18

2. Nociceptive pain assessed by the PainDETECT questionnaire may predict response to opioid treatment for chronic low back pain;Heliyon;2024-02

3. Cannabis for medical use versus opioids for chronic non-cancer pain: a systematic review and network meta-analysis of randomised clinical trials;BMJ Open;2024-01

4. Liver Metabolomics and Inflammatory Profiles in Mouse Model of Fentanyl Overdose Treated with Beta-Lactams;Metabolites;2023-08-21

5. Between guidelines and clinical trials: evidence-based advice on the pharmacological management of non-specific chronic low back pain;BMC Musculoskeletal Disorders;2023-05-30